PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Fibrose cística - Insuficiência pancreática Fibrose cística - Insuficiência pancreática Subcommitte, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108(5):832-9. 22. Proesmans M De Boeck K. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes. Eur J Ped. 2003;162(11):760-3. Epub 2003 Sep 17. 23. Baker SS. Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis. Ther Clin Risk Manag. 2008;4(5):1079-84. 24. Kraisinger M, Hochhaus G, Stecenko A, Bowser E, Hendeles L. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol. 1994;34(2):158-66. 311